US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Odyssey Therapeutics

24.80

+0.28501.16%

Volume:46.01K

Turnover:1.13M

Market Cap:1.19B

PE:-7.42

High:25.38

Open:24.09

Low:24.09

Close:24.51

52wk High:29.05

52wk Low:15.10

Shares:48.03M

Float Shares:13.24M

Volume Ratio:1.44

T/O Rate:0.35%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.3410

EPS(LYR):-50.1297

ROE:-85.50%

ROA:-41.66%

PB:2.83

PE(LYR):-0.49

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

HC Wainwright Initiates Odyssey Therapeutics at Buy With $44 Price Target

MT Newswires Live

Odyssey Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $44

THOMSON REUTERS

Odyssey Therapeutics to Participate in Upcoming Investor Conferences

Odyssey Therapeutics is Maintained at Overweight by JP Morgan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/ODTX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ODTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODTX\",,,,,undefined,":{"symbol":"ODTX","market":"US","secType":"STK","nameCN":"Odyssey Therapeutics","latestPrice":24.795,"timestamp":1789050657718,"preClose":24.51,"halted":0,"volume":46008,"delay":0,"changeRate":0.011627906976744191,"floatShares":13240000,"shares":48031300,"eps":-3.341,"marketStatus":"Trading","change":0.285,"latestTime":"09-10 10:30:59 EDT","open":24.09,"high":25.38,"low":24.09,"amount":1128514.8653280002,"amplitude":0.052632,"askPrice":24.89,"askSize":200,"bidPrice":24.63,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-3.341,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"listingDate":1778212800000,"exchange":"NASDAQ","adjPreClose":24.51,"preHourTrading":{"tag":"盘前","latestPrice":26.7347,"preClose":24.51,"latestTime":"07:30 EDT","volume":4,"amount":105.454696,"timestamp":1789039856399,"change":2.2247,"changeRate":0.090767,"amplitude":0.093023},"postHourTrading":{"tag":"盘后","latestPrice":24.51,"preClose":24.51,"latestTime":"19:30 EDT","volume":1903,"amount":46736.11,"timestamp":1788996608135,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.438867},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ODTX\",,,,,undefined,":{"symbol":"ODTX","floatShares":13240000,"roa":"-41.66%","roe":"-85.50%","lyrEps":-50.129685,"volumeRatio":1.438867,"shares":48031300,"dividePrice":0,"high":25.38,"amplitude":0.052632,"preClose":24.51,"low":24.09,"week52Low":15.1,"pbRate":"2.83","psRate":"12029.66","week52High":29.05,"institutionHeld":0,"latestPrice":24.795,"committee":-0.333333,"eps":-3.341,"divideRate":0,"volume":46008,"delay":0,"ttmEps":-3.341,"open":24.09,"prevYearClose":18,"prevWeekClose":28.76,"prevMonthClose":24.52,"prevQuarterClose":18.71,"fiveDayClose":26.62,"twentyDayClose":21.58,"sixtyDayClose":17.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ODTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"ODTX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ODTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ODTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1787889600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ODTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ODTX","date":"2026-09-09","current":-7.336127,"percent":0.012048,"low":-8.61189,"twenty":-6.506229,"median":-5.731052,"eighty":-5.409767,"high":-5.017591,"avg":-6.060871,"sd":0.831759,"marketCap":1292360839},"quantilePoints":[{"date":"2026-05-08","current":-5.722186,"twenty":-5.722186,"median":-5.722186,"eighty":-5.722186,"marketCap":850585842},{"date":"2026-05-15","current":-5.496622,"twenty":-5.693383,"median":-5.609284,"eighty":-5.496622,"marketCap":817056381},{"date":"2026-05-22","current":-5.629912,"twenty":-5.680689,"median":-5.537878,"eighty":-5.38396,"marketCap":836869527},{"date":"2026-05-29","current":-5.687036,"twenty":-5.681958,"median":-5.553746,"eighty":-5.441085,"marketCap":845360875},{"date":"2026-06-05","current":-5.395068,"twenty":-5.640067,"median":-5.507729,"eighty":-5.381104,"marketCap":801960652},{"date":"2026-06-12","current":-5.33477,"twenty":-5.599446,"median":-5.433151,"eighty":-5.365236,"marketCap":792997562},{"date":"2026-06-18","current":-5.864756,"twenty":-5.646414,"median":-5.455366,"eighty":-5.369045,"marketCap":871778402},{"date":"2026-06-26","current":-5.739918,"twenty":-5.704904,"median":-5.528358,"eighty":-5.374757,"marketCap":852228560},{"date":"2026-07-02","current":-5.356182,"twenty":-5.790223,"median":-5.545812,"eighty":-5.374122,"marketCap":795253729},{"date":"2026-07-10","current":-5.427125,"twenty":-5.732825,"median":-5.496622,"eighty":-5.359042,"marketCap":805786891},{"date":"2026-07-17","current":-5.501292,"twenty":-5.710665,"median":-5.510065,"eighty":-5.36714,"marketCap":816798833},{"date":"2026-07-24","current":-5.697997,"twenty":-5.732825,"median":-5.553746,"eighty":-5.374122,"marketCap":846004419},{"date":"2026-07-31","current":-5.939848,"twenty":-5.856557,"median":-5.572788,"eighty":-5.377217,"marketCap":881912925},{"date":"2026-08-07","current":-6.447481,"twenty":-5.942427,"median":-5.59659,"eighty":-5.382058,"marketCap":1031771093},{"date":"2026-08-14","current":-6.204393,"twenty":-6.026914,"median":-5.668975,"eighty":-5.382691,"marketCap":992870470},{"date":"2026-08-21","current":-7.387181,"twenty":-6.093162,"median":-5.678649,"eighty":-5.386182,"marketCap":1182148383},{"date":"2026-08-28","current":-7.779447,"twenty":-6.206789,"median":-5.687036,"eighty":-5.395703,"marketCap":1244921564},{"date":"2026-09-04","current":-7.905212,"twenty":-6.445274,"median":-5.710091,"eighty":-5.402083,"marketCap":1265047317},{"date":"2026-09-09","current":-8.075892,"twenty":-6.506229,"median":-5.731052,"eighty":-5.409767,"marketCap":1292360839}],"updateTime":1789038394533},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ODTX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662701047","title":"HC Wainwright Initiates Odyssey Therapeutics at Buy With $44 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2662701047","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662701047?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:33","pubTimestamp":1787830439,"startTime":"0","endTime":"0","summary":"Odyssey Therapeutics, Inc. (ODTX) has an average rating of buy and mean price target of $35.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ODTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703638","title":"Odyssey Therapeutics, Inc. : H.c. Wainwright Initiates Coverage with Buy Rating and Target Price $44","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703638?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:12","pubTimestamp":1787825531,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nAZN4TGPAB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ODTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662719875","title":"Odyssey Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2662719875","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662719875?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:00","pubTimestamp":1787745600,"startTime":"0","endTime":"0","summary":"BOSTON, Aug.  26, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351300/0/en/odyssey-therapeutics-to-participate-in-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ODTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657409156","title":"Odyssey Therapeutics is Maintained at Overweight by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2657409156","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657409156?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:26","pubTimestamp":1786119960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ODTX/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ODTX\",params:#limit:6,delay:false,,,undefined,":[]}}